At Bonus Biogroup, we are pioneering the future of regenerative medicine. Our groundbreaking technologies and innovative approach are bound to help millions live better and longer lives
At Bonus Biogroup, we are pioneering the future of regenerative medicine. Our groundbreaking technologies and innovative approach are bound to help millions live better and longer lives
Bonus Biogroup is leading the way in the development of innovative technologies that harness the power of adipose-derived stromal cells. Our unique approach has the potential to treat a wide range of diseases involving tissue damage, inflammation, and autoimmunity.
CELL THERAPY
Our cell therapies represent a living pharmacy, capable of deploying multiple therapeutics simultaneously, offering a more comprehensive treatment approach than single-drug therapies.
TISSUE ENGINEERING
Our tissue engineering approach recognizes that creating viable tissues requires a diverse range of cells working together, much like a community.
Bonus Biogroup is leading the way in the development of innovative technologies that harness the power of adipose-derived stromal cells. Our unique approach has the potential to treat a wide range of diseases involving tissue damage, inflammation, and autoimmunity.
CELL THERAPY
Our cell therapies represent a living pharmacy, capable of deploying multiple therapeutics simultaneously, offering a more comprehensive treatment approach than single-drug therapies.
TISSUE ENGINEERING
Our tissue engineering approach recognizes that creating viable tissues requires a diverse range of cells working together, much like a community.
Bonus Biogroup was a lifeline for me. As I lay in intensive care battling respiratory distress and severe COVID, I found it increasingly difficult to breathe and began saying my goodbyes to my wife and children. However, just hours after receiving MesenCure, I felt my breathing improve. A few days later, I was discharged from the hospital in fair condition. This is the power of Bonus Biogroup's innovative cell therapy.
Francis Kaldawy
(former patient treated with MesenCure™)
Bonus Biogroup was a lifeline for me. As I lay in intensive care battling respiratory distress and severe COVID, I found it increasingly difficult to breathe and began saying my goodbyes to my wife and children. However, just hours after receiving MesenCure, I felt my breathing improve. A few days later, I was discharged from the hospital in fair condition. This is the power of Bonus Biogroup's innovative cell therapy.
Francis Kaldawy
(former patient treated with MesenCure™)
As a physician, I believe in shaping the future of medicine, and Bonus Biogroup is doing just that. Their product, BonoFill™, is an engineered tissue designed to treat the most challenging bone defects. It's safe, effective, and affordable, marking a significant advancement in orthopedics.
Prof. Nimrod Rozen
(President of the Israeli Association of Orthopedic Surgeons)
As a physician, I believe in shaping the future of medicine, and Bonus Biogroup is doing just that. Their product, BonoFill™, is an engineered tissue designed to treat the most challenging bone defects. It's safe, effective, and affordable, marking a significant advancement in orthopedics.
Prof. Nimrod Rozen
(President of the Israeli Association of Orthopedic Surgeons)
MesenCure™
Cell Therapy Reinvented
Like Francis Kaldawy, two-thirds of severely ill respiratory distress patients have had their lives saved by MesenCure, our next-generation off-the-shelf cell therapy for acute inflammations and tissue damage. MesenCure™, with its unique expression of nearly seven thousand genes, is safer and more effective than previous-generation products, marking a new era in cell therapy.
BonoFill™
Bridging the Widest Gaps
BonoFill™ has helped dozens of patients with severe disabilities caused by large defects in their facial and limb bones regain normal function. BonoFill™ is a personalized, viable bone graft made from a high-density culture of the patient's own cells. It's designed to fit all bone gap sizes and indications, ensuring optimal reconstruction and helping patients swiftly return to their everyday lives.
MesenCure™
Cell Therapy Reinvented
Like Francis Kaldawy, two-thirds of severely ill respiratory distress patients have had their lives saved by MesenCure, our next-generation off-the-shelf cell therapy for acute inflammations and tissue damage. MesenCure™, with its unique expression of nearly seven thousand genes, is safer and more effective than previous-generation products, marking a new era in cell therapy.
BonoFill™
Bridging the Widest Gaps
BonoFill™ has helped dozens of patients with severe disabilities caused by large defects in their facial and limb bones regain normal function. BonoFill™ is a personalized, viable bone graft made from a high-density culture of the patient's own cells. It's designed to fit all bone gap sizes and indications, ensuring optimal reconstruction and helping patients swiftly return to their everyday lives.
INVEST AND JOIN US IN BUILDING
A BETTER TOMORROW
I founded Bonus Biogroup with the mission to address urgent and unmet clinical needs and to make a significant impact on global health. This journey would not have been possible without the vision and dedication of our team of scientists, technologists, and business partners, who have joined us in forging this pioneering path in regenerative medicine.
Dr. Shai Meretzki, CEO and Founder
INVEST AND JOIN US IN BUILDING
A BETTER TOMORROW
I founded Bonus Biogroup with the mission to address urgent and unmet clinical needs and to make a significant impact on global health. This journey would not have been possible without the vision and dedication of our team of scientists, technologists, and business partners, who have joined us in forging this pioneering path in regenerative medicine.
Dr. Shai Meretzki, CEO and Founder
info@bonus-bio.com
+972 (0)73 206 7104
Matam Advanced Technology
